Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin

被引：0
|
作者：
Liwei Meng
Liming Huang
Yingchun Xu
Wei Zhang
机构：
[1] Shaoxing People’s Hospital (Shaoxing Hospital of Zhejiang University),Department of Breast and Thyroid Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Breast cancer; Interstitial pneumonitis; Pegylated liposomal doxorubicin; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 7
页数：4
相关论文
共 50 条
  • [21] Pegylated liposomal doxorubicin in ovarian cancer
    Green, Andrew E.
    Rose, Peter G.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 229 - 239
  • [22] Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer
    Smith, Thomas J.
    Hillner, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : E128 - E128
  • [23] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Huober, Jens
    Fett, Werner
    Nusch, Arnd
    Neise, Michael
    Schmidt, Marcus
    Wischnik, Arthur
    Gerhardt, Steffen
    Goehler, Thomas
    Lueck, Hans-Joachim
    Rost, Andreas
    BMC CANCER, 2010, 10
  • [24] Retrospective study for pegylated liposomal doxorubicin in adjuvant breast cancer therapy
    Lu, Y.
    Hsieh, C.
    Hou, M.
    Ou-Yang, F.
    Chang, K.
    Chen, D.
    Wang, H.
    BREAST, 2009, 18 : S53 - S54
  • [25] Prevention of palmoplantar erythrodysesthesia in patients treated with pegylated liposomal doxorubicin (CaelyxA®)
    Jung, S.
    Sehouli, J.
    Chekerov, R.
    Kluschke, F.
    Patzelt, A.
    Fuss, H.
    Knorr, F.
    Lademann, J.
    SUPPORTIVE CARE IN CANCER, 2017, 25 (11) : 3545 - 3549
  • [26] Prevention of palmoplantar erythrodysesthesia in patients treated with pegylated liposomal doxorubicin (Caelyx®)
    S. Jung
    J. Sehouli
    R. Chekerov
    F. Kluschke
    A. Patzelt
    H. Fuss
    F. Knorr
    J. Lademann
    Supportive Care in Cancer, 2017, 25 : 3545 - 3549
  • [27] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Jens Huober
    Werner Fett
    Arnd Nusch
    Michael Neise
    Marcus Schmidt
    Arthur Wischnik
    Steffen Gerhardt
    Thomas Goehler
    Hans-Joachim Lück
    Andreas Rost
    BMC Cancer, 10
  • [28] Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
    Anders, Carey K.
    Adamo, Barbara
    Karginova, Olga
    Deal, Allison M.
    Rawal, Sumit
    Darr, David
    Schorzman, Allison
    Santos, Charlene
    Bash, Ryan
    Kafri, Tal
    Carey, Lisa
    Miller, C. Ryan
    Perou, Charles M.
    Sharpless, Norman
    Zamboni, William C.
    PLOS ONE, 2013, 8 (05):
  • [29] Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier
    Recchia, Francesco
    Candeloro, Giampiero
    Guerriero, Gabriele
    Piazze, Juan
    Desideri, Giovambattista
    Necozione, Stefano
    Rea, Silvio
    ANTI-CANCER DRUGS, 2010, 21 (05) : 559 - 564
  • [30] Pembrolizumab plus pegylated liposomal Doxorubicin for Patients with Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (01) : 19 - 20
12345